Fundz

Aether Biomedical Announces Series A Funding Round Close, Pushes Forward Future Of Upper Limb Prosthetics

PRIVATENov 13, 2023

Round Type

Series A

BiotechnologyHealth CareArtificial IntelligenceMedical DeviceMachine Learning

Investors

Chiratae VenturesStory VenturesJ2 Ventures

Description

Aether Biomedical, a biotech company creating cutting-edge bionic prosthetics, today announced the successful conclusion of a $5.8 Million Series A funding round, led by J2 Ventures and Story Ventures. The round also included participation from existing partner, Chiratae Ventures. The new capital will enable Aether’s experienced team to expand manufacturing options for their premier product, The Zeus hand, and advance research and development, with the mission of creating healthcare technology and robotics that are based on human-centered design. Notably, Aether has committed 75% of its current workforce to research and development.

Quick answer

Aether Biomedical raised an undisclosed amount in a Series A round, dated November 13, 2023. Investors: Chiratae Ventures, Story Ventures and J2 Ventures.

How much did Aether Biomedical raise?
Aether Biomedical raised an undisclosed amount in a Series A round on November 13, 2023.
Who invested in Aether Biomedical?
Chiratae Ventures, Story Ventures and J2 Ventures are named as investors in this round.
What does Aether Biomedical do?
Aether Biomedical was founded on the premise of creating healthcare technology and robotics based on human-centered design.
Who are the decision-makers at Aether Biomedical?
Fundz holds 1 contact at Aether Biomedical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as Aether Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • Laza Medical raised $36M (Series A) on December 12, 2023.
  • Laza Medical raised $25M on November 24, 2023.
  • Healwell AI raised $30K (Pre-Seed) on October 17, 2023.
  • Cursor raised $8M (Funding Round) on October 11, 2023.
  • Ordaos raised $500K (Seed) on December 22, 2023.
  • Nalu Medical raised $115M on December 21, 2023.

Who to call at Aether Biomedical, and when

A new round usually means Aether Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aether Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aether Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aether Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aether Biomedical

About

Aether Biomedical was founded on the premise of creating healthcare technology and robotics based on human-centered design. A culture focused on building the next generation of bionic devices, utilizing cutting-edge biosignal processing and software integration. After an expansion in Europe and Asia, we are now launching Zeus to the U.S market, with our U.S. headquarters in Chicago, IL. We have developed the Zeus hand, which is the strongest multi-articulating myoelectric hand in the world, providing 30-40% more grip force (152 Newtons) than existing market options! Apart from being the strongest hand, Zeus is highly robust as well. This is due to its patent-pending impact resistance mechanism which allows the fingers to flex when facing any impact, protecting them from breakage. Zeus is the first bionic hand that you can repair completely, within your workshop, in under 30 minutes. Incorporating 12 customizable grip patterns and a variety of control mechanisms. Zeus can be truly tailored to the patient’s usage profile. In conjunction with the Zeus hand, we are creating a digital ecosystem of mobile and software applications to improve the patient experience via technology and analytics. Zeus is supported by state-of-the-art web-based software that allows configuration of the hand via the web without the need to download applications to a computer. This web software allows you to track the history of the setting changes

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aether Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Aether Biomedical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Aether Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.